JP2022512540A5 - - Google Patents

Info

Publication number
JP2022512540A5
JP2022512540A5 JP2021511583A JP2021511583A JP2022512540A5 JP 2022512540 A5 JP2022512540 A5 JP 2022512540A5 JP 2021511583 A JP2021511583 A JP 2021511583A JP 2021511583 A JP2021511583 A JP 2021511583A JP 2022512540 A5 JP2022512540 A5 JP 2022512540A5
Authority
JP
Japan
Prior art keywords
chimeric protein
cells
amino acid
acid sequence
domain
Prior art date
Application number
JP2021511583A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020047327A5 (https=
JP2022512540A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048922 external-priority patent/WO2020047327A2/en
Publication of JP2022512540A publication Critical patent/JP2022512540A/ja
Publication of JPWO2020047327A5 publication Critical patent/JPWO2020047327A5/ja
Publication of JP2022512540A5 publication Critical patent/JP2022512540A5/ja
Priority to JP2024075517A priority Critical patent/JP2024096361A/ja
Pending legal-status Critical Current

Links

JP2021511583A 2018-08-29 2019-08-29 Ｆｌｔ３ｌ系キメラタンパク質 Pending JP2022512540A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075517A JP2024096361A (ja) 2018-08-29 2024-05-07 Ｆｌｔ３ｌ系キメラタンパク質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862724596P 2018-08-29 2018-08-29
US62/724,596 2018-08-29
PCT/US2019/048922 WO2020047327A2 (en) 2018-08-29 2019-08-29 Flt3l-based chimeric proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075517A Division JP2024096361A (ja) 2018-08-29 2024-05-07 Ｆｌｔ３ｌ系キメラタンパク質

Publications (3)

Publication Number Publication Date
JP2022512540A JP2022512540A (ja) 2022-02-07
JPWO2020047327A5 JPWO2020047327A5 (https=) 2022-09-06
JP2022512540A5 true JP2022512540A5 (https=) 2022-09-06

Family

ID=69643788

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021511583A Pending JP2022512540A (ja) 2018-08-29 2019-08-29 Ｆｌｔ３ｌ系キメラタンパク質
JP2024075517A Withdrawn JP2024096361A (ja) 2018-08-29 2024-05-07 Ｆｌｔ３ｌ系キメラタンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075517A Withdrawn JP2024096361A (ja) 2018-08-29 2024-05-07 Ｆｌｔ３ｌ系キメラタンパク質

Country Status (9)

Country Link
US (1) US20240122983A1 (https=)
EP (1) EP3843755A4 (https=)
JP (2) JP2022512540A (https=)
CN (1) CN112888711A (https=)
AU (1) AU2019333175A1 (https=)
CA (1) CA3109352A1 (https=)
IL (1) IL281088A (https=)
MX (1) MX2021002289A (https=)
WO (1) WO2020047327A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20210687A (es) * 2019-06-25 2022-03-03 Gilead Sciences Inc PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
JP2023506501A (ja) * 2019-12-16 2023-02-16 ワシントン・ユニバーシティ キメラ抗原受容体樹状細胞（ｃａｒ－ｄｃ）ならびにこれを作製および使用する方法
WO2022089418A1 (zh) * 2020-10-26 2022-05-05 信达生物制药(苏州)有限公司 重组截短FLT3配体与人抗体Fc的融合蛋白
WO2024123812A1 (en) 2022-12-05 2024-06-13 Shattuck Labs, Inc. Fusion proteins for the treatment of cardiometabolic diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK782002A3 (en) * 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
EP1276501B9 (en) * 2000-04-25 2007-01-24 Immunex Corporation Method for treatment of tumors using photodynamic therapy
MXPA03003632A (es) * 2000-10-24 2003-09-10 Immunex Corp Metodo para tratamiento de tumores usando terapia de combinacion.
CN101198621A (zh) * 2005-01-25 2008-06-11 阿波罗生命科学有限公司 分子及其嵌合分子
WO2014043215A1 (en) * 2012-09-11 2014-03-20 The Texas A&M University System Bi-specifc diabodies for masking and targeting vaccines
RU2766200C1 (ru) * 2015-10-01 2022-02-09 Хит Байолоджикс, Инк. Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков
JP6898325B2 (ja) * 2015-12-08 2021-07-07 ユニバーシティ−インダストリー・ファンデーション・ヨンセイ・ユニバーシティ ＧＭ−ＣＳＦ遺伝子；Ｆｌｔ３Ｌ−ＴＲＡＩＬ融合遺伝子；ＴＧＦ−βの発現を抑制するｓｈＲＮＡ；およびＨＳＰ発現を抑制するｓｈＲＮＡを含む抗腫瘍組成物

Similar Documents

Publication Publication Date Title
US20230295567A1 (en) Methods for culturing cells and kits and apparatus for same
ES3038614T3 (en) Oligomeric particle reagents and methods of use thereof
Liu et al. The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component
CN108135998B (zh) 高亲合力hpv t细胞受体
JP2018531035A6 (ja) 細胞を培養するための方法ならびにそのためのキットおよび装置
JP2022512540A5 (https=)
JP2017522893A (ja) Ｒｏｒ１特異的多重鎖キメラ抗原受容体
JP2023521966A (ja) 改変ｂ細胞及びその使用方法
JP2020508063A5 (https=)
KR20240103033A (ko) 키메라 항원 수용체 요법 t 세포 확장 동역학 및 그의 용도
WO2018058432A1 (zh) 一种多基因重组嵌合抗原受体分子及其应用
TW202012436A (zh) 嵌合hla輔助(accessory)受體
CN118853566A (zh) 一种肿瘤浸润淋巴细胞的培养方法及培养基
CN116239692B (zh) 分离的抗体、包含该抗体的car及其用途
JPWO2020047327A5 (https=)
Klein T-cell activation in the curious world of the intestinal intraepithelial lymphocyte
EP4382119A1 (en) A kit for use in the treatment of hematological cancer
WO2025011609A1 (zh) 细胞治疗产品制备工艺及其应用
WO2025232760A1 (zh) 特异性结合Claudin18.2的嵌合抗原受体免疫细胞及其应用
WO2024099990A1 (en) TGF-ß SWITCH RECEPTOR CAR T CELLS
KR20260052956A (ko) TGFβ 스위치 수용체, 이를 코딩하는 핵산, 이를 포함하는 세포 및 약학 조성물
WO2024121297A1 (en) A kit for use in the treatment of hematological cancer
WO2024146398A1 (zh) 分离的抗体、包含该抗体的car及其用途
WO2024131750A1 (zh) T细胞抗原受体及其制备方法和应用
KR20260032929A (ko) 암 및 바이러스 질환을 치료하기 위한 il21 뮤테인을 함유하는 융합 단백질